Menu
Back to Journals » Vascular Health and Risk Management » Volume 5
Cardiovascular disease in patients with chronic kidney disease
Authors Wright J, Hutchison A
Published 26 August 2009 Volume 2009:5 Pages 713—722
DOI https://doi.org/10.2147/VHRM.S6206
Review by Single anonymous peer review
Peer reviewer comments 3
Julian Wright, Alastair Hutchison
Manchester Institute of Nephrology and Transplantation, Manchester Royal Infirmary, Manchester, UK
Abstract: Patients with chronic kidney disease have a high burden of cardiovascular morbidity and mortality. The vast majority of patients with chronic kidney disease do not progress to end stage renal failure, but do have a significantly higher incidence of all cardiovascular co-morbidities. Traditional cardiovascular risk factors only partially account for this increased incidence of cardiovascular disease. In patients with kidney disease the basic biology underlying cardiovascular disease may be similar to that in patients without kidney disease, but it would seem many more risk factors are involved as a consequence of renal dysfunction. Although emphasis is placed on delaying the progression of chronic kidney disease, it must be appreciated that for many patients it is vital to address their cardiovascular risk factors at an early stage to prevent premature cardiovascular death. This review examines available epidemiological evidence, discusses common cardiovascular risk factors in patients with chronic kidney disease, and suggests possible treatment strategies. Potential areas for important research are also described.
Keywords: cardiovascular risk factors, chronic kidney disease, hypertension, diabetes
© 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.